Cleared Traditional

K896522 - DOCUMENT(TM) TOTAL AND DIRECT BILIRUBIN LINEARITY

K896522 is an FDA 510(k) clearance for DOCUMENT(TM) TOTAL AND DIRECT BILIRUBIN..., manufactured by Casco Standards. The device is a Class 1 Chemistry device with product code JJY cleared through the Traditional 510(k) pathway after a 48-day FDA review.

K896522 · Casco Standards · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1990
Decision
48d
Days
Class 1
Risk

K896522 is an FDA 510(k) clearance for the DOCUMENT(TM) TOTAL AND DIRECT BILIRUBIN LINEARITY. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Casco Standards (Yarmouth, US). The FDA issued a Cleared decision on January 2, 1990 after a review of 48 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Casco Standards devices

FDA 510(k) Submission Details - K896522

510(k) Number K896522 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 15, 1989
Decision Date January 02, 1990
Days to Decision 48 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 88d · This submission: 48d
Pathway characteristics
Predicate-based equivalence.

JJY Device Classification - Class 1, General Controls

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 594
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K896522.
LYPHOCHEK WHOLE BLOOD CONTROL (HUMAN) LEVELS 1,2,3
K895905 · Bio-Rad · Jan 1990
CLP COMPREHENSIVE LIPID CONTROL-LR
K896246 · Creative Laboratory Products, Inc. · Jan 1990
CLP COMPREHENSIVE LIPID CONTROL-HR
K896247 · Creative Laboratory Products, Inc. · Jan 1990
NORMAL AND ABNORMAL CONTROL SERA
K895943 · Sclavo, Inc. · Dec 1989
SERACHEM PLUS CLINICAL CHEMISTRY CONTROLS
K894852 · Instrumentation Laboratory CO · Sep 1989
LYPHOCHEK(R) TUMOR MARKER CONTROLS, LEVELS I & II
K894078 · Bio-Rad · Aug 1989